Editorial
The Human Immunodeficiency Virus (HIV) Epidemic in Singapore—Where Are We Now, and Can We “Get to Zero”?
December 1, 2012 marked the global community’s 25th observance of World Acquired Immune Deficiency Syndrome (AIDS) Day. The Joint United Nations Programme on human...
Original Article
Clinical Evaluation of an In-House Human Immunodeficiency Virus (HIV) Genotyping Assay for the Detection of Drug Resistance Mutations in HIV-1 Infected Patients in Singapore
Human immunodeficiency virus (HIV) drug resistance testing is a standard of care test recommended for HIV-infected patients prior to initiation of antiretroviral therapy (treatment-naïve),...
Original Article
Unexpected Drug-Drug Interactions in Human Immunodeficiency Virus (HIV) Therapy: Induction of UGT1A1 and Bile Efflux Transporters by Efavirenz
Major improvements in antiretroviral therapy have transformed human immunodeficiency virus (HIV) infection into a manageable chronic disease. More and more patients are starting therapy...
Original Article
Causes of Death and Factors Associated with Early Death Among Human Immunodeficiency Virus (HIV)-Infected Persons in Singapore: Pre-Highly Active Antiretroviral Therapy (HAART) and Peri-HAART
Since the first case of human immunodeficiency virus (HIV) was diagnosed in Singapore in May 1985, a total of 4845 cases and 1389 HIV/acquired...
Original Article
Causes of Death in Hospitalised Human Immunodeficiency Virus (HIV)-infected Patients at a National Referral Centre in Singapore: A Retrospective Review from 2008 to 2010
The advent of the highly active antiretroviral therapy (HAART) era has greatly reduced the mortality and incidence of new diagnoses of acquired immune deficiency...